- Home
- FSM vs TVTX Comparison
FSM vs TVTX Comparison
Compare FSM & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSM | TVTX |
|---|---|---|
| Founded | 1990 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FSM | TVTX |
|---|---|---|
| Price | $9.74 | $34.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 15 |
| Target Price | $11.00 | ★ $37.21 |
| AVG Volume (30 Days) | ★ 7.0M | 1.4M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 809.52 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $1,256,829,000.00 | $435,826,000.00 |
| Revenue This Year | $0.28 | $120.36 |
| Revenue Next Year | $11.64 | $37.33 |
| P/E Ratio | $12.97 | ★ N/A |
| Revenue Growth | 68.17 | ★ 114.22 |
| 52 Week Low | $4.13 | $12.91 |
| 52 Week High | $10.38 | $37.50 |
Technical Indicators
Market Signals| Indicator | FSM | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | 54.45 |
| Support Level | $9.17 | $33.84 |
| Resistance Level | $10.08 | $35.97 |
| Average True Range (ATR) | 0.43 | 1.42 |
| MACD | 0.02 | -0.36 |
| Stochastic Oscillator | 71.12 | 31.85 |
Price Performance
Historical ComparisonAbout FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.